Aa. Brandes et al., Endocrine dysfunctions in patients treated for brain tumors: incidence andguidelines for management, J NEURO-ONC, 47(1), 2000, pp. 85-92
Endocrine alterations are frequently found in patients undergoing treatment
for CNS tumors. Careful follow-up aimed at the early detection of recurren
ces, with life-long monitor of hypothalamus-pituitary (HP) function, will a
lso reveal any endocrine dysfunctions; indeed, their appropriate diagnosis
and treatment may determine a significant improvement in the quality of lif
e of these patients.